These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11884431)

  • 1. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.
    Golovina TN; Wherry EJ; Bullock TN; Eisenlohr LC
    J Immunol; 2002 Mar; 168(6):2667-75. PubMed ID: 11884431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope.
    Gallimore A; Schwarz K; van den Broek M; Hengartner H; Groettrup M
    Mol Immunol; 1998 Jul; 35(10):581-91. PubMed ID: 9823757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
    Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
    J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.
    Smith DC; Gallimore A; Jones E; Roberts B; Lord JM; Deeks E; Cerundolo V; Roberts LM
    J Immunol; 2002 Jul; 169(1):99-107. PubMed ID: 12077234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
    Cerundolo V; Benham A; Braud V; Mukherjee S; Gould K; Macino B; Neefjes J; Townsend A
    Eur J Immunol; 1997 Jan; 27(1):336-41. PubMed ID: 9022037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
    Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
    J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides.
    Antón LC; Snyder HL; Bennink JR; Vinitsky A; Orlowski M; Porgador A; Yewdell JW
    J Immunol; 1998 May; 160(10):4859-68. PubMed ID: 9590233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of class I-restricted epitope processing by local or distal flanking sequence.
    Yellen-Shaw AJ; Eisenlohr LC
    J Immunol; 1997 Feb; 158(4):1727-33. PubMed ID: 9029109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental.
    Guil S; Rodríguez-Castro M; Aguilar F; Villasevil EM; Antón LC; Del Val M
    J Biol Chem; 2006 Dec; 281(52):39925-34. PubMed ID: 17088258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis.
    Mukherjee P; Dani A; Bhatia S; Singh N; Rudensky AY; George A; Bal V; Mayor S; Rath S
    J Immunol; 2001 Sep; 167(5):2632-41. PubMed ID: 11509605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
    López D; Gil-Torregrosa BC; Bergmann C; Del Val M
    J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein.
    Yellen-Shaw AJ; Wherry EJ; Dubois GC; Eisenlohr LC
    J Immunol; 1997 Apr; 158(7):3227-34. PubMed ID: 9120278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies.
    Anton LC; Yewdell JW; Bennink JR
    J Immunol; 1997 Mar; 158(6):2535-42. PubMed ID: 9058784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
    Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
    J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
    Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells.
    Serna A; Ramirez MC; Soukhanova A; Sigal LJ
    J Immunol; 2003 Dec; 171(11):5668-72. PubMed ID: 14634072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential processing of influenza nucleoprotein in human and mouse cells.
    Braud VM; McMichael AJ; Cerundolo V
    Eur J Immunol; 1998 Feb; 28(2):625-35. PubMed ID: 9521073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the specificity and cooperation of aminopeptidases in the cytosol and endoplasmic reticulum during MHC class I antigen presentation.
    Hearn A; York IA; Bishop C; Rock KL
    J Immunol; 2010 May; 184(9):4725-32. PubMed ID: 20351195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
    Bai A; Forman J
    J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.